Percentage of patients with a clinical event in the intention to treat population (n = 819)
| Clinical event | Nisoldipine (n=408) | Placebo (n=411) | p Value |
|---|---|---|---|
| Events are counted as not mutually exclusive. | |||
| *Repeat PTCA of a lesion dilated at baseline. | |||
| †PTCA of a lesion that was not dilated at baseline. | |||
| AMI, acute myocardial infarction; CABG, coronary artery bypass graft; CVA, cerebrovascular accident; PTCA, percutaneous transluminal coronary angioplasty. | |||
| Death | 2.9 | 3.4 | NS |
| CVA | 1.0 | 1.7 | NS |
| AMI | 3.9 | 3.2 | NS |
| CABG | 5.1 | 10 | <0.01 |
| Repeat PTCA* | 30.6 | 37.7 | 0.03 |
| PTCA† | 15.7 | 16.3 | NS |
| Repeat PTCA and CABG | 2.7 | 4.6 | NS |
| Repeat PTCA + PTCA† | 6.1 | 8.8 | NS |
| Total | 44.6 | 52.6 | 0.02 |